Related Experiment Video
Updated: Sep 8, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Nomograms for primary mucinous ovarian cancer: A SEER population-based study
Xueling Qi1, Luxi Xu1, Juan Wang1
1Wuxi Medical School, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214000, P.R. China; Department of Obstetrics and Gynecology, Affiliated Hospital of Jiangnan University, 1000 Hefeng Road, Wuxi, Jiangsu 214000, P.R. China.
Predictive nomograms for primary mucinous ovarian cancer (PMOC) survival were developed using SEER data. These tools accurately predict overall survival (OS) and cancer-specific survival (CSS), aiding clinical treatment decisions.
Area of Science:
- Oncology
- Biostatistics
- Medical Informatics
Background:
- Primary mucinous ovarian cancer (PMOC) survival prediction requires robust tools.
- Existing models may not fully capture the nuances of PMOC prognosis.
Purpose of the Study:
- To develop and validate predictive nomograms for overall survival (OS) and cancer-specific survival (CSS) in patients with PMOC.
- To identify independent risk factors influencing survival outcomes in PMOC.
Main Methods:
- Utilized data from 991 PMOC patients (2010-2015) from the SEER database.
- Employed univariate and multivariate Cox regression analyses to identify risk factors.
- Constructed and validated nomograms using training and validation cohorts, assessing with C-index and AUC.
Main Results:
- Identified age, laterality, AJCC stage, and grade as independent risk factors for OS and CSS.
- Developed nomograms showed high predictive accuracy in both training and validation cohorts (C-indices ranging from 0.80 to 0.88).
- Calibration plots confirmed good consistency between predicted and actual survival outcomes.
Conclusions:
- The developed nomograms demonstrate strong predictability for PMOC patient survival.
- These nomograms can serve as valuable clinical tools for refining treatment strategies.
- The study provides a data-driven approach to enhance prognostic accuracy in PMOC.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010